| Haleon Plc (HLN) | |||
|---|---|---|---|
| 10.17 0.03 (0.3%) | 10-20 16:00 | ||
| Open: | 10.16 | Pre. Close: | 10.14 |
| High: | 10.25 | Low: | 10.115 |
| Volume: | 18,761,630 | Market Cap: | 44,724(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 11.97  One year: 13.98 |
| Support: | Support1: 9.27 Support2: 8.67 |
| Resistance: | Resistance1: 10.25 Resistance2: 11.97 |
| Pivot: | 9.39 |
| Moving Averages: | MA(5): 10.01 MA(20): 9.33 MA(100): 9.49 MA(250): 9.63 |
| MACD: | MACD(12,26): 0.17 Signal(12,26,9): 0.03 |
| %K %D: | %K(14,3): 97.10 %D(3): 96.41 |
| RSI: | RSI(14): 71.65 |
| 52-Week: | High: 11.28 Low: 8.65 Change(%): 11.2 |
| Average Vol(K): | 3-Month: 15131 10-Days: 17185 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 10.256 - 10.286 | 10.286 - 10.32 |
| Low: | 10.017 - 10.054 | 10.054 - 10.096 |
| Close: | 10.104 - 10.161 | 10.161 - 10.224 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ HLN ] has closed below upper band by 11.2%. Bollinger Bands are 137.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue. |
| Company profile |
|---|
| Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty & Generic | |
| Shares Out. (M) | 4400.00 |
| Shares Float (M) | 4430.00 |
| % Held by Insiders | 0.01 |
| % Held by Institutions | 13.64 |
| Shares Short (K) | 24840 |
| Shares Short Prior Month (K) | 15370 |
| Stock Financials | |
|---|---|
| EPS | 0.490 |
| Book Value (p.s.) | 4.880 |
| Profit Margin | 14.55 |
| Operating Margin | 23.94 |
| Return on Assets (ttm) | 5.1 |
| Return on Equity (ttm) | 10.1 |
| Qtrly Rev. Growth | 2.2 |
| Gross Profit (p.s.) | 1.661 |
| Sales Per Share | 2.534 |
| EBITDA (p.s.) | 0.648 |
| Qtrly Earnings Growth | -4.50 |
| Operating Cash Flow (M) | 2650.00 |
| Levered Free Cash Flow (M) | 1800.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | 20.76 |
| PEG Ratio | 2.13 |
| Price to Book value | 2.08 |
| Price to Sales | 4.01 |
| Price to Cash Flow | 16.89 |
| Stock Dividends | |
|---|---|
| Dividend | 0.060 |
| Dividend Yield | 0.01 |
| Dividend Growth | |
